Avalo Therapeutics
About Avalo Therapeutics
Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune dysregulation. Avalo’s lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases.
For more information about Avalo, please visit www.avalotx.com.
Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success.
We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases.
Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
Find Avalo Therapeutics Execs' Valid Emails
Up to 90% verified emails and mobile numbers, refreshed weekly.
Company Details
0-500K
Biotechnology
11-50 employees
Public Company
Chesterbrook, Pennsylvania
United States
Frequently Asked Questions about
What is Avalo Therapeutics's industry?
Avalo Therapeutics operates in the Biotechnology industry and is headquartered in United States.
How many employees does Avalo Therapeutics have?
Avalo Therapeutics has approximately 11-50 employees employees.
Where is Avalo Therapeutics's based?
Avalo Therapeutics is based in Chesterbrook, Pennsylvania, United States.
Is Avalo Therapeutics publicly listed?
Yes. Avalo Therapeutics is a publicly traded company.
How can I contact Avalo Therapeutics's investor relations team?
You can reach Avalo Therapeutics’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Find verified emails and phone numbers for professionals like those at
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
Find verified emails at this company
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.